BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30560357)

  • 1. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
    Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
    Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
    Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
    Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma.
    Rhee H; Lim HJ; Han K; Yeom SK; Choi SH; Park JH; Cho ES; Park S; Lee MJ; Choi GH; Han DH; Lee SS; Park MS
    Hepatol Int; 2023 Aug; 17(4):942-953. PubMed ID: 36689090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
    Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
    World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
    Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.
    Chung T; Rhee H; Shim HS; Yoo JE; Choi GH; Kim H; Park YN
    Gut Liver; 2022 Jul; 16(4):613-624. PubMed ID: 34810298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
    Fujita N; Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Moirta K; Shirabe K; Aishima S; Wang H; Oda Y; Honda H
    Eur Radiol; 2017 Feb; 27(2):498-506. PubMed ID: 27165138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
    Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
    J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.